- Home
- JRVR vs TKNO Comparison
JRVR vs TKNO Comparison
Compare JRVR & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JRVR | TKNO |
|---|---|---|
| Founded | 2002 | 1996 |
| Country | United States | United States |
| Employees | 578 | N/A |
| Industry | Property-Casualty Insurers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.7M | 138.1M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | JRVR | TKNO |
|---|---|---|
| Price | $6.15 | $2.71 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.33 | N/A |
| AVG Volume (30 Days) | ★ 260.9K | 131.6K |
| Earning Date | 03-02-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.64% | N/A |
| EPS Growth | ★ 125.82 | 43.86 |
| EPS | ★ 0.79 | N/A |
| Revenue | ★ $687,614,000.00 | $40,520,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | $1.61 | $13.13 |
| P/E Ratio | $7.96 | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $3.85 | $1.91 |
| 52 Week High | $7.20 | $7.48 |
Technical Indicators
Market Signals| Indicator | JRVR | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 40.57 | 49.36 |
| Support Level | $6.07 | $1.97 |
| Resistance Level | $6.88 | $5.39 |
| Average True Range (ATR) | 0.19 | 0.25 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 30.56 | 34.55 |
Price Performance
Historical ComparisonAbout JRVR James River Group Holdings Ltd.
James River Group Holdings Inc is a holding company that owns and operates a group of specialty insurance companies focused on underwriting small and middle market casualty risks within the U.S. excess and surplus (E&S) lines market. The Company operates in two specialty property-casualty insurance segments: Excess and Surplus Lines and Specialty Admitted Insurance.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.